Pancreaticoduodenectomy in Combination with Superior Mesenteric-Portal Vein Resection for Adenocarcinoma in Pancreas: a Report of 25 Cases

Xi Chen
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2005.05.008
2005-01-01
Abstract:Objective To investigate the morbidity,mortality and survival rate after pancreaticoduodenectomy in combination with en bloc superior mesenteric-portal vein(SMPV) resection for adenocarcinoma in pancreas.Methods Twenty-five patients with adenocarcinoma in pancreas receiving pancreaticoduodenectomy in combination with SMPV resection in our hospital were reviewed.Meanwhile,they were pathologically categorized into 2 groups: group A,compression of the venous wall without true invasion;group B,true vein invasion.Results The morbidity was 32.0% and there was no operative mortality.1-and 2-year survival rates were 56.0% and 28.0%,respectively.There were no significant differences in morbidity and survival rate between the 2 groups.Conclusions If candidates are carefully selected,pancreaticoduodenectomy in combination with SMPV resection can be safely performed without increased morbidity and mortality.However,whether it can improve the survival rate should be further explored.
What problem does this paper attempt to address?